TargetChymotrypsinogen A(Bos taurus (bovine))
Glaxo Wellcome Research And Development
Curated by ChEMBL
Glaxo Wellcome Research And Development
Curated by ChEMBL
Affinity DataIC50: 1.60E+3nMAssay Description:Concentration of the compound required to inhibit the mammalian Chymotrypsinogen by 50% was determinedMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human cytomegalovirus (strain AD169) (HHV-5) (Huma...)
Glaxo Wellcome Research And Development
Curated by ChEMBL
Glaxo Wellcome Research And Development
Curated by ChEMBL
Affinity DataIC50: 6.50E+3nMAssay Description:Concentration of the compound required to inhibit the mutant alpha-Ala HCMV protease by 50% was determinedMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human cytomegalovirus (strain AD169) (HHV-5) (Huma...)
Glaxo Wellcome Research And Development
Curated by ChEMBL
Glaxo Wellcome Research And Development
Curated by ChEMBL
Affinity DataIC50: 1.70E+4nMAssay Description:Concentration of the compound required to inhibit the mutant alpha-Ala HCMV protease by 50% was determinedMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human cytomegalovirus (strain AD169) (HHV-5) (Huma...)
Glaxo Wellcome Research And Development
Curated by ChEMBL
Glaxo Wellcome Research And Development
Curated by ChEMBL
Affinity DataIC50: 2.00E+4nMAssay Description:Concentration of the compound required to inhibit the mutant alpha-Ala HCMV protease by 50% was determinedMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human cytomegalovirus (strain AD169) (HHV-5) (Huma...)
Glaxo Wellcome Research And Development
Curated by ChEMBL
Glaxo Wellcome Research And Development
Curated by ChEMBL
Affinity DataIC50: 2.70E+4nMAssay Description:Concentration of the compound required to inhibit the mutant alpha-Ala HCMV protease by 50% was determinedMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human cytomegalovirus (strain AD169) (HHV-5) (Huma...)
Glaxo Wellcome Research And Development
Curated by ChEMBL
Glaxo Wellcome Research And Development
Curated by ChEMBL
Affinity DataIC50: 4.20E+4nMAssay Description:Concentration of the compound required to inhibit the mutant alpha-Ala HCMV protease by 50% was determinedMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human cytomegalovirus (strain AD169) (HHV-5) (Huma...)
Glaxo Wellcome Research And Development
Curated by ChEMBL
Glaxo Wellcome Research And Development
Curated by ChEMBL
Affinity DataIC50: 5.00E+4nMAssay Description:Concentration of the compound required to inhibit the mutant alpha-Ala HCMV protease by 50% was determinedMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human cytomegalovirus (strain AD169) (HHV-5) (Huma...)
Glaxo Wellcome Research And Development
Curated by ChEMBL
Glaxo Wellcome Research And Development
Curated by ChEMBL
Affinity DataIC50: 6.80E+4nMAssay Description:Concentration of the compound required to inhibit the mutant alpha-Ala HCMV protease by 50% was determinedMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human cytomegalovirus (strain AD169) (HHV-5) (Huma...)
Glaxo Wellcome Research And Development
Curated by ChEMBL
Glaxo Wellcome Research And Development
Curated by ChEMBL
Affinity DataIC50: 8.60E+4nMAssay Description:Concentration of the compound required to inhibit the mutant alpha-Ala HCMV protease by 50% was determinedMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human cytomegalovirus (strain AD169) (HHV-5) (Huma...)
Glaxo Wellcome Research And Development
Curated by ChEMBL
Glaxo Wellcome Research And Development
Curated by ChEMBL
Affinity DataIC50: >1.00E+5nMAssay Description:Concentration of the compound required to inhibit the mutant alpha-Ala HCMV protease by 50% was determinedMore data for this Ligand-Target Pair
TargetAcetylcholinesterase(Homo sapiens (Human))
Glaxo Wellcome Research And Development
Curated by ChEMBL
Glaxo Wellcome Research And Development
Curated by ChEMBL
Affinity DataIC50: >1.00E+5nMAssay Description:Concentration of the compound required to inhibit the mammalian Acetylcholinesterase by 50% was determinedMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human cytomegalovirus (strain AD169) (HHV-5) (Huma...)
Glaxo Wellcome Research And Development
Curated by ChEMBL
Glaxo Wellcome Research And Development
Curated by ChEMBL
Affinity DataIC50: >1.00E+5nMAssay Description:Concentration of the compound required to inhibit the mutant alpha-Ala HCMV protease by 50% was determinedMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human cytomegalovirus (strain AD169) (HHV-5) (Huma...)
Glaxo Wellcome Research And Development
Curated by ChEMBL
Glaxo Wellcome Research And Development
Curated by ChEMBL
Affinity DataIC50: >1.00E+5nMAssay Description:Concentration of the compound required to inhibit the mutant alpha-Ala HCMV protease by 50% was determinedMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human cytomegalovirus (strain AD169) (HHV-5) (Huma...)
Glaxo Wellcome Research And Development
Curated by ChEMBL
Glaxo Wellcome Research And Development
Curated by ChEMBL
Affinity DataIC50: >1.00E+5nMAssay Description:Concentration of the compound required to inhibit the mutant alpha-Ala HCMV protease by 50% was determinedMore data for this Ligand-Target Pair
TargetAcetylcholinesterase(Homo sapiens (Human))
Glaxo Wellcome Research And Development
Curated by ChEMBL
Glaxo Wellcome Research And Development
Curated by ChEMBL
Affinity DataIC50: >1.00E+5nMAssay Description:Concentration of the compound required to inhibit the mammalian Acetylcholinesterase by 50% was determinedMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human cytomegalovirus (strain AD169) (HHV-5) (Huma...)
Glaxo Wellcome Research And Development
Curated by ChEMBL
Glaxo Wellcome Research And Development
Curated by ChEMBL
Affinity DataIC50: >1.00E+5nMAssay Description:Concentration of the compound required to inhibit the mutant alpha-Ala HCMV protease by 50% was determinedMore data for this Ligand-Target Pair
TargetChymotrypsinogen A(Bos taurus (bovine))
Glaxo Wellcome Research And Development
Curated by ChEMBL
Glaxo Wellcome Research And Development
Curated by ChEMBL
Affinity DataIC50: >1.00E+5nMAssay Description:Concentration of the compound required to inhibit the mammalian Chymotrypsinogen by 50% was determinedMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human cytomegalovirus (strain AD169) (HHV-5) (Huma...)
Glaxo Wellcome Research And Development
Curated by ChEMBL
Glaxo Wellcome Research And Development
Curated by ChEMBL
Affinity DataIC50: >1.00E+5nMAssay Description:Concentration of the compound required to inhibit the mutant alpha-Ala HCMV protease by 50% was determinedMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human cytomegalovirus (strain AD169) (HHV-5) (Huma...)
Glaxo Wellcome Research And Development
Curated by ChEMBL
Glaxo Wellcome Research And Development
Curated by ChEMBL
Affinity DataIC50: >1.00E+5nMAssay Description:Concentration of the compound required to inhibit the mutant alpha-Ala HCMV protease by 50% was determinedMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human cytomegalovirus (strain AD169) (HHV-5) (Huma...)
Glaxo Wellcome Research And Development
Curated by ChEMBL
Glaxo Wellcome Research And Development
Curated by ChEMBL
Affinity DataIC50: 1.00E+5nMAssay Description:Concentration of the compound required to inhibit the mutant alpha-Ala HCMV protease by 50% was determinedMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human cytomegalovirus (strain AD169) (HHV-5) (Huma...)
Glaxo Wellcome Research And Development
Curated by ChEMBL
Glaxo Wellcome Research And Development
Curated by ChEMBL
Affinity DataIC50: >1.00E+5nMAssay Description:Concentration of the compound required to inhibit the mutant alpha-Ala HCMV protease by 50% was determinedMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human cytomegalovirus (strain AD169) (HHV-5) (Huma...)
Glaxo Wellcome Research And Development
Curated by ChEMBL
Glaxo Wellcome Research And Development
Curated by ChEMBL
Affinity DataIC50: >1.00E+5nMAssay Description:Concentration of the compound required to inhibit the mutant alpha-Ala HCMV protease by 50% was determinedMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human cytomegalovirus (strain AD169) (HHV-5) (Huma...)
Glaxo Wellcome Research And Development
Curated by ChEMBL
Glaxo Wellcome Research And Development
Curated by ChEMBL
Affinity DataIC50: >1.00E+5nMAssay Description:Concentration of the compound required to inhibit the mutant alpha-Ala HCMV protease by 50% was determinedMore data for this Ligand-Target Pair